HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
2020 · Cancer Discovery · 279 citations
https://doi.org/10.1158/2159-8290.cd-20-0215
E
Emiliano Cocco
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
271
Papers
6.7K
Citations
44
h-index
85
i10-index
Emiliano Cocco is an academic researcher from University of Miami. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Lung Cancer Treatments and Mutations & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 44, co-authored 231 publications.
ORCID: 0000-0002-1397-2656Papers by this author
worksARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
2020 · Nature Genetics · 225 citations
https://doi.org/10.1038/s41588-019-0554-0
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
2009 · British Journal of Cancer · 112 citations
https://doi.org/10.1038/sj.bjc.6605448
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
2022 · Nature Communications · 105 citations
https://doi.org/10.1038/s41467-022-28848-x
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019 · Proceedings of the National Academy of Sciences · 93 citations
https://doi.org/10.1073/pnas.1911385116
Prevalence and role of HER2 mutations in cancer
2019 · Pharmacology & Therapeutics · 79 citations
https://doi.org/10.1016/j.pharmthera.2019.03.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat